News

Each cancer center may only see a small handful of patients with a given rare tumor a year, making the collection of living tissue samples—at the scale required to create laboratory cell models to drive research—nearly impossible. To be able to develop the model derivation effort in this disease, the Cancer Cell Line Factory (CCLF), plans to […]

The American Association for Cancer Research (AACR) issued the following press release focused on the Angiosarcoma Project, whose work is guided by Angiosarcoma Awareness, Inc.’s Vice President Dr. Corrie Painter.   A Patient-partnered Genomics Study Identifies Immunotherapy as Potential Treatment for a Rare Cancer 9/30/2018 ​NEW YORK — Angiosarcoma Project, a patient-partnered genomics study, identified […]

A new Phase II clinical trial targeting angiosarcoma is now recruiting patients at Boston’s Massachusetts General Hospital and the Dana-Farber Cancer Institute. For details on this and other available trials, check out the recently updated clinical trials page of our website, which is located under our Resources section.  

After taking a year off for a strategic re-brand, we are excited to unveil the return of our community’s beloved 5K event, revamped for its 7th year, in its new location in Herter Park in Boston, MA! Registration is NOW OPEN for the 2018 We Will Prevail 5K- Run, Walk, & Kids Race Benefiting Angiosarcoma […]

Because angiosarcoma is an exceedingly rare cancer, it has never been the focus of large scale scientific endeavors. However, patients are now able to participate in two research projects aimed at understanding this disease in order to make discoveries which may lead to better therapeutic options. Please visit both projects below for more information:   […]

     We are pleased to announce that Angiosarcoma Awareness, Inc. has entered into a unique year-long collaboration with a fellow rare cancer advocacy organization, TargetCancer Foundation (TCF). This partnership will leverage the strengths of our respective organizations towards our common goal of supporting patients and research into rare cancers like angiosarcoma. Below is the post originally published by TCF announcing the partnership […]

“I knew I was making progress when Tory said to me, ‘I forgot I had cancer for an entire day’ with happy tears rolling down her cheeks. My heart was full.” – Julie S. If summer brings to mind fond memories of spending time outdoors, swapping stories by starlight with wonderful friends, laughter, and adventure, […]

ASCproject.org Please help us spread the word about the Angiosarcoma Project, which was recently launched as a collaboration between the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute. People from across the country and Canada can sign up to provide consent that would allow the researchers of this study to obtain copies […]